FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer

Authors:

Abstract
FOXA family proteins act as pioneer factors by remodeling compact chromatin structures. FOXA1 is crucial for the chromatin binding of the androgen receptor (AR) in both normal prostate epithelial cells and the luminal subtype of prostate cancer (PCa). Recent studies have highlighted the emergence of FOXA2 as an adaptive response to AR signaling inhibition treatments. However, the role of the FOXA1 to FOXA2 transition in regulating cancer lineage plasticity remains unclear. Our study demonstrates that FOXA2 binds to distinct classes of developmental enhancers in multiple AR-independent PCa subtypes, with its binding depending on LSD1. Moreover, we reveal that FOXA2 collaborates with JUN at chromatin and promotes transcriptional reprogramming of AP-1 in lineage-plastic cancer cells, thereby facilitating cell state transitions to multiple lineages. Overall, our findings underscore the pivotal role of FOXA2 as a pan-plasticity driver that rewires AP-1 to induce the differential transcriptional reprogramming necessary for cancer cell lineage plasticity.
Funding Information
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA211350, U54CA156734, U54 CA156734)
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute
  • United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-19-1-0361, W81XWH-21-1-0267, W81XWH-19-1-0777)
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute
  • Movember Foundation (MNBCF-17-012, MNBCF-17-012)
  • Department of Health, State Government of Victoria (MCRF15023)
  • Department of Health, State Government of Victoria (MCRF18017)
  • Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (142246, 159567)

This publication has 61 references indexed in Scilit: